← Back to headlines
Pfizer Announces Late-Stage Trial Success for Multiple Myeloma Therapy Elrexfio
Pfizer has announced a successful outcome in a late-stage clinical trial for its multiple myeloma therapy, Elrexfio. This marks a significant development in the treatment options for the blood cancer.
29 Apr, 15:17 — 29 Apr, 15:17
Sources
Showing 1 of 1 sources
Related Stories
France Relaxes Cheese Production Rules After Historic Drought
17m ago
Analysts Upgrade Price Targets for Nvidia and CrowdStrike Following Strong Earnings
32m ago
Fed Officials Outline Policy Priorities at Jackson Hole Ahead of Leadership Transition
35m ago
Dollar Tree Beats Q2 Earnings Estimates and Raises Full-Year Guidance
40m ago